Rationalizing nose-to-brain drug delivery: Machine learning-guided optimization and mechanistic elucidation of olfactory deposition for nasal sprays.

Nose-to-brain drug delivery via nasal sprays is severely limited by low olfactory deposition. In this study, we integrate machine learning with high-throughput experimentation to systematically optimize olfactory deposition of solid lipid nanoparticle-loaded nasal sprays (SLN-NS). By engineering the dispersed medium properties using five excipients at varying concentrations across 40 formulations, we establish a three-level interlocking correlation among dispersed medium properties, spray performance, and olfactory deposition. We demonstrate that basic physicochemical properties predominantly influence microscopic droplet characteristics, while dynamic rheological parameters dictate macroscopic spray morphology. A random forest model accurately predicted olfactory deposition and guided the design of an optimized formulation, achieving 19.77% olfactory deposition, representing a 4 to 20-fold improvement over conventional nasal sprays. In vivo studies confirmed enhanced brain delivery and superior therapeutic efficacy in animal models of migraine, Alzheimer's, and Parkinson's diseases. This work provides a rational framework for optimizing nasal spray formulations to overcome anatomical barriers for improved CNS drug delivery.

• Publication year

  2026

• Venue

  Journal of Controlled Release

• Publication date

  2026-01-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.jconrel.2026.114667PMID 41617015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Developing machine learning for heterogeneous catalysis with experimental and computational data.

  2025cited by this paper
• A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease

  2025cited by this paper
• Lab-in-the-loop machine learning for brain-targeting delivery system design

  2025cited by this paper
• Studying Noncovalent Interactions in Molecular Systems with Machine Learning

  2025cited by this paper
• Machine learning reshapes the paradigm of nanomedicine research

  2025cited by this paper
• Characterization and Inverse Design of Stochastic Mechanical Metamaterials Using Neural Operators

  2025cited by this paper
• Nose‐to‐Brain Delivery of Circular RNA SCMH1‐Loaded Lipid Nanoparticles for Ischemic Stroke Therapy

  2025cited by this paper
• Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy

  2025cited by this paper
• Olfaction and drug delivery to the human olfactory airspace: current challenges and recent advances

  2025cited by this paper
• Engineered commensals for targeted nose-to-brain drug delivery.

  2025cited by this paper
• Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery

  2025cited by this paper
• Enhanced Nasal-to-Brain Drug Delivery by Multivalent Bioadhesive Nanoparticle Clusters for Cerebral Ischemic Reperfusion Injury Protection.

  2025cited by this paper
• Tailored Borneol-Modified Lipid Nanoparticles Nasal Spray for Enhanced Nose-to-Brain Delivery to Central Nervous System Diseases.

  2024cited by this paper
• Organic crystal structure prediction via coupled generative adversarial networks and graph convolutional networks

  2024cited by this paper
• Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.

  2024cited by this paper
• Lyotropic Liquid Crystalline Based Nasal Spray for Improved Parkinson's Treatment: Enhanced Superior Nasal Tract Deposition and Antioxidation Strategy

  2024cited by this paper
• Immune mechanisms and shared immune targets in neurodegenerative diseases

  2024cited by this paper
• Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery

  2024cited by this paper
• Visualization and Estimation of Nasal Spray Delivery to Olfactory Mucosa in an Image-Based Transparent Nasal Model

  2023cited by this paper
• The blood–brain barrier: Structure, regulation and drug delivery

  2023cited by this paper
• An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines.

  2023cited by this paper
• Incisionless targeted adeno-associated viral vector delivery to the brain by focused ultrasound-mediated intranasal administration

  2022cited by this paper
• Drug delivery to the central nervous system

  2021cited by this paper
• Approval of esketamine for treatment-resistant depression.

  2020cited by this paper
• Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.

  2020cited by this paper
• Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study

  2020cited by this paper
• In vitro Assessment of an Idealized Nose for Nasal Spray Testing: Comparison with Regional Deposition in Realistic Nasal Replicas.

  2020cited by this paper
• Nose-to-Brain Delivery

  2019cited by this paper
• Partitioning of dispersed nanoparticles in a realistic nasal passage for targeted drug delivery

  2018cited by this paper
• Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols.

  2016cited by this paper
• Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

  2008cited by this paper

• No citing papers are available for this paper.